Latest research from Patersons indicates this stock has been re-rated from Speculative Buy to Buy and have a prce target of just under $9 (due to currency fluctuations)....
At these levels, this is excellect buying...Have a look at the buy side... its building very nicely thank you...
- Forums
- ASX - By Stock
- stock has been re rated
stock has been re rated
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online